Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04378114 · ClinicalTrials.gov registry record · NA
Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT04378114: Completed NA study, sponsored by Medtronic MiniMed.
NCT04378114 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04378114, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the impact of acetaminophen ingestion on the performance of the Guardian™ Sensor (3) (i.e., C algorithm and Zeus algorithm) in subjects age 18 - 80 years.
Interventions
- DRUG Acetominophen
- DEVICE Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter. C sensor algorithm applied retrospectively to raw sensor data.
- DEVICE Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter. Zeus sensor algorithm applied retrospectively to raw sensor data.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2020-05-18 |
| Est. Completion | 2020-07-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04378114
The ClinicalTrials.gov registry entry for NCT04378114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Acetominophen is the first listed.
NCT04378114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04378114 about?
NCT04378114 is a clinical study titled "Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults". The purpose of this study is to characterize the impact of acetaminophen ingestion on the performance of the Guardian™ Sensor (3) (i.e., C algorithm and Zeus algorithm) in subjects age 18 - 80 years.
What is the current status of trial NCT04378114?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2020-05-18. Estimated completion is 2020-07-17.
What interventions are being tested in trial NCT04378114?
The interventions under investigation include: Acetominophen (DRUG), Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter. C sensor algorithm applied retrospectively to raw sensor data. (DEVICE), Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter. Zeus sensor algorithm applied retrospectively to raw sensor data. (DEVICE).
Who is sponsoring clinical trial NCT04378114?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.